Numerous compounds are under evaluation as immunological adjuvants for improvement of vaccine performance. This review will briefly summarize some of the many diverse substances that are currently being utilized as vaccine adjuvants in preclinical and clinical studies.
No takes yet. Share an insight, caveat, or question.
Charlotte R. Kensil (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: